Next Financial Group’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,782
Closed -$15K 979
2020
Q1
$15K Sell
2,782
-535
-16% -$4.78K ﹤0.01% 1378
2019
Q4
$30K Buy
3,317
+420
+14% +$3.41K ﹤0.01% 1382
2019
Q3
$21K Buy
2,897
+392
+16% +$2.81K ﹤0.01% 1425
2019
Q2
$20K Buy
2,505
+150
+6% +$1.78K ﹤0.01% 1457
2019
Q1
$29K Buy
2,355
+2,320
+6,629% +$36.7K 0.01% 868
2018
Q4
$1K Buy
+35
New +$810 ﹤0.01% 1835

Other funds holding EVH

Next Financial Group's EVH Position: Q2 2020 in Review

Next Financial Group sold out of Evolent Health (EVH) in Q2 2020, closing a stake of 2,782 shares — an estimated $15K sold.

Next Financial Group first reported a position in EVH in Q4 2018 and held it in 6 quarters. The position peaked at $30K in Q4 2019. 136 funds tracked by Wall St. Rank hold EVH as of Q2 2020.

  • Next Financial Group reported no remaining Evolent Health position as of Q2 2020 after selling out during the quarter.
  • Next Financial Group sold 2,782 Evolent Health shares in Q2 2020, an estimated $15K.
  • Next Financial Group first reported a position in Evolent Health in Q4 2018 and held it in 6 quarters.
  • Next Financial Group's Evolent Health position peaked at $30K in Q4 2019.
  • 136 funds tracked by Wall St. Rank held Evolent Health as of Q2 2020.

Based on Next Financial Group's 13F filing for Q2 2020, filed 24 Jul 2020.